Literature DB >> 23819028

Premature menopause in young breast cancer: effects on quality of life and treatment interventions.

Shoshana M Rosenberg1, Ann H Partridge.   

Abstract

Many young women are at increased risk for premature menopause following adjuvant treatment for breast cancer. These women must deal with consequences of menopause, including loss of fertility and physiologic symptoms such as night sweats, hot flashes, vaginal dryness, and weight gain. These symptoms can be particularly distressing for young women and can adversely affect both health-related and psychosocial quality of life (QOL). While there are a wide range of pharmacologic and non-pharmacologic interventions available to help with these symptoms and in turn, improve QOL, there is little data available about the use and efficacy of these interventions in younger women who become menopausal as a result of their breast cancer treatment. Future studies should focus on this vulnerable population, with the goal of identifying effective strategies to relieve symptoms and improve quality of life in young breast cancer survivors.

Entities:  

Keywords:  Premature menopause; breast cancer; quality of life (QOL); young women

Year:  2013        PMID: 23819028      PMCID: PMC3695534          DOI: 10.3978/j.issn.2072-1439.2013.06.20

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  72 in total

Review 1.  Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review.

Authors:  Jessica Howard-Anderson; Patricia A Ganz; Julienne E Bower; Annette L Stanton
Journal:  J Natl Cancer Inst       Date:  2012-01-23       Impact factor: 13.506

2.  Menopausal-type symptoms in young breast cancer survivors.

Authors:  M G Leining; S Gelber; R Rosenberg; M Przypyszny; E P Winer; A H Partridge
Journal:  Ann Oncol       Date:  2006-09-13       Impact factor: 32.976

3.  Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.

Authors:  Annelies H Boekhout; Andrew D Vincent; Otilia B Dalesio; Joan van den Bosch; Joke H Foekema-Töns; Sandra Adriaansz; Sylvia Sprangers; Bastiaan Nuijen; Jos H Beijnen; Jan H M Schellens
Journal:  J Clin Oncol       Date:  2011-09-12       Impact factor: 44.544

4.  Cognitive effects of chemotherapy-induced menopause in breast cancer.

Authors:  Katharine J Vearncombe; Margaret Rolfe; Brooke Andrew; Nancy A Pachana; Margaret Wright; Geoffrey Beadle
Journal:  Clin Neuropsychol       Date:  2011-11-02       Impact factor: 3.535

5.  Risk of menopause during the first year after breast cancer diagnosis.

Authors:  P J Goodwin; M Ennis; K I Pritchard; M Trudeau; N Hood
Journal:  J Clin Oncol       Date:  1999-08       Impact factor: 44.544

6.  Potential adverse impact of ovariectomy on physical and psychological function of younger women with breast cancer.

Authors:  Padaphet Sayakhot; Amanda Vincent; Amanda Deeks; Helena Teede
Journal:  Menopause       Date:  2011-07       Impact factor: 2.953

7.  Weight gain and quality of life in women treated with adjuvant chemotherapy for early-stage breast cancer.

Authors:  J A McInnes; M T Knobf
Journal:  Oncol Nurs Forum       Date:  2001-05       Impact factor: 2.172

8.  Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.

Authors:  Leena Vehmanen; Inkeri Elomaa; Carl Blomqvist; Tiina Saarto
Journal:  J Clin Oncol       Date:  2006-02-01       Impact factor: 44.544

9.  Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.

Authors:  A Benshushan; N Rojansky; M Chaviv; S Arbel-Alon; A Benmeir; T Imbar; A Brzezinski
Journal:  Climacteric       Date:  2009-10       Impact factor: 3.005

10.  Body image in recently diagnosed young women with early breast cancer.

Authors:  Shoshana M Rosenberg; Rulla M Tamimi; Shari Gelber; Kathryn J Ruddy; Sandra Kereakoglow; Virginia F Borges; Steven E Come; Lidia Schapira; Eric P Winer; Ann H Partridge
Journal:  Psychooncology       Date:  2012-11-07       Impact factor: 3.894

View more
  25 in total

1.  Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors.

Authors:  Leslie R Schover; George P Baum; Lisa A Fuson; Abenaa Brewster; Amal Melhem-Bertrandt
Journal:  J Sex Med       Date:  2014-08-21       Impact factor: 3.802

Review 2.  Breast cancer: an update on treatment-related infertility.

Authors:  Erica Silvestris; Miriam Dellino; Paola Cafforio; Angelo Virgilio Paradiso; Gennaro Cormio; Stella D'Oronzo
Journal:  J Cancer Res Clin Oncol       Date:  2020-01-31       Impact factor: 4.553

3.  Correlates of quality of life in overweight or obese breast cancer survivors at enrollment into a weight loss trial.

Authors:  Bilgé Pakiz; Patricia A Ganz; Rebecca L Sedjo; Shirley W Flatt; Wendy Demark-Wahnefried; Jingxia Liu; Kathleen Y Wolin; Cheryl L Rock
Journal:  Psychooncology       Date:  2015-04-29       Impact factor: 3.894

Review 4.  Breast cancer: insights in disease and influence of drug methotrexate.

Authors:  Vítor Yang; Maria João Gouveia; Joana Santos; Beate Koksch; Irina Amorim; Fátima Gärtner; Nuno Vale
Journal:  RSC Med Chem       Date:  2020-05-28

5.  The mediating effect of pleasure and menopausal symptoms on sexual activity among young breast cancer survivors.

Authors:  Shiran Klein; Shani Paluch-Shimon; Michal Braun
Journal:  Support Care Cancer       Date:  2022-02-26       Impact factor: 3.603

6.  Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer Survivors.

Authors:  Cheryl L Rock; Shirley W Flatt; Tim E Byers; Graham A Colditz; Wendy Demark-Wahnefried; Patricia A Ganz; Kathleen Y Wolin; Anthony Elias; Helen Krontiras; Jingxia Liu; Michael Naughton; Bilgé Pakiz; Barbara A Parker; Rebecca L Sedjo; Holly Wyatt
Journal:  J Clin Oncol       Date:  2015-08-17       Impact factor: 44.544

7.  Menses resumption after cancer treatment-induced amenorrhea occurs early or not at all.

Authors:  Melanie H Jacobson; Ann C Mertens; Jessica B Spencer; Amita K Manatunga; Penelope P Howards
Journal:  Fertil Steril       Date:  2015-12-01       Impact factor: 7.329

8.  A comparison of physical activity correlates across breast, prostate and colorectal cancer survivors in Nova Scotia, Canada.

Authors:  Cynthia C Forbes; Chris M Blanchard; W Kerry Mummery; Kerry S Courneya
Journal:  Support Care Cancer       Date:  2013-11-16       Impact factor: 3.603

9.  Bone Health in Premenopausal Chinese Patients after Adjuvant Chemotherapy for Early Breast Cancer.

Authors:  Claudia H W Yip; Giok S Liem; Frankie K F Mo; Elizabeth Pang; Yuan-Yuan Lei; Leung Li; Christopher C H Yip; Jane Koh; Rita Y W Ng; Joyce J S Suen; Winnie Yeo
Journal:  Breast Care (Basel)       Date:  2020-03-18       Impact factor: 2.860

10.  The Impact of COVID-19 Outbreak on Emotional and Cognitive Vulnerability in Iranian Women With Breast Cancer.

Authors:  Mohammad H Choobin; Vida Mirabolfathi; Bethany Chapman; Ali Reza Moradi; Elizabeth A Grunfeld; Nazanin Derakshan
Journal:  Front Psychol       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.